Cargando…

On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation

The demand of platelet transfusions is steadily growing worldwide, inter-donor variation, donor dependency, or storability/viability being the main contributing factors to the current global, donor-dependent platelet concentrate shortage concern. In vitro platelet production has been proposed as a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Botía, Patricia, Acebes-Huerta, Andrea, Seghatchian, Jerard, Gutiérrez, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761839/ https://www.ncbi.nlm.nih.gov/pubmed/33287459 http://dx.doi.org/10.3390/medicina56120671

Ejemplares similares

Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity
por: Seghatchian, Jerard
Publicado: (2022)

In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!
por: Seghatchian, Jerard
Publicado: (2020)

In vitro Generation of Megakaryocytes and Platelets
por: Liu, Huicong, et al.
Publicado: (2021)

Effect of YAP/TAZ on megakaryocyte differentiation and platelet production
por: Lorthongpanich, Chanchao, et al.
Publicado: (2020)

Inhibition of ferroptosis promotes megakaryocyte differentiation and platelet production
por: Song, Baoquan, et al.
Publicado: (2022)

MXRA7 is involved in megakaryocyte differentiation and platelet production
por: Sun, Zhenjiang, et al.
Publicado: (2023)

The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned
por: Seghatchian, Jerard
Publicado: (2020)

Platelet and extracellular vesicles in COVID-19 infection and its vaccines
por: Goubran, Hadi, et al.
Publicado: (2022)

Updates on Stem Cell Therapy in Transfusion Medicine, New Approaches to RBC Substitution Therapy, the Use of IFC for the Assessment of Extracellular- Derived Vesicles/Exosomes
por: Seghatchian, Jerard
Publicado: (2020)

Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount
por: Seghatchian, Jerard
Publicado: (2021)

New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, Jerard
Publicado: (2021)

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
por: Seghatchian, Jerard
Publicado: (2022)

Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes
por: Seghatchian, Jerard
Publicado: (2022)

Spotlight on SARS CoV-2 infection inducing autoimmunity, through the formation of autoantibody to self hemostatic components or to host cells, often leading to severe thrombotic or bleeding events
por: Seghatchian, Jerard
Publicado: (2023)

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

The Application of Ethnomedicine in Modulating Megakaryocyte Differentiation and Platelet Counts
por: Yang, Fei, et al.
Publicado: (2023)

Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production
por: Krisch, Linda, et al.
Publicado: (2021)

Effects of Estrogens on Platelets and Megakaryocytes
por: Dupuis, Marion, et al.
Publicado: (2019)

Transcription factors in megakaryocytes and platelets
por: Yuan, Hengjie, et al.
Publicado: (2023)

Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes
Publicado: (1981)

Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity
por: Lanza, Francesco, et al.
Publicado: (2020)

An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research
por: Putter, Jeffrey S., et al.
Publicado: (2020)

“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
por: Burnouf, Thierry, et al.
Publicado: (2014)

Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
por: Amiral, Jean, et al.
Publicado: (2023)

T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
por: Putter, Jeffrey S., et al.
Publicado: (2023)

Megakaryocyte rupture for acute platelet needs
por: Nieswandt, Bernhard, et al.
Publicado: (2015)

The role of platelets and megakaryocytes in bone metastasis
por: Leblanc, Raphael, et al.
Publicado: (2016)

Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated Megakaryocytes
por: Silvagno, Francesca, et al.
Publicado: (2010)

OP9 Bone Marrow Stroma Cells Differentiate into Megakaryocytes and Platelets
por: Matsubara, Yumiko, et al.
Publicado: (2013)

Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin
por: Abd-Elrahman, I, et al.
Publicado: (2013)

The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation
por: Liu, Cuicui, et al.
Publicado: (2021)

Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
por: Murphy, Andrew J., et al.
Publicado: (2013)

Manipulating megakaryocytes to manufacture platelets ex vivo
por: Karagiannis, P, et al.
Publicado: (2015)

The platelet fibrinogen receptor: from megakaryocyte to the mortuary
por: Floyd, Christopher N, et al.
Publicado: (2012)

Interactions of periodontal pathogens with megakaryocytic cells and platelets
por: Andrews, A.M., et al.
Publicado: (2017)

The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
por: De Kock, Lore, et al.
Publicado: (2020)

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases
por: Assinger, Alice, et al.
Publicado: (2023)

Reprogramming megakaryocytes to engineer platelets as delivery vehicles
por: Javdan, Shwan B., et al.
Publicado: (2023)

Blood Platelets Are Assembled Principally at the Ends of Proplatelet Processes Produced by Differentiated Megakaryocytes
por: Italiano, Joseph E., et al.
Publicado: (1999)

Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_2drv4hbb53ck2iqra2sg6afdus